MYD88 Mutations Predict Unfavorable Prognosis in Chronic Lymphocytic Leukemia Patients With Mutated IGHV Gene

Blood Cancer Journal- United States

doi 10.1038/s41408-017-0014-y

Full Text

Abstract

Available in

Categories

Date

December 1, 2017

Authors

Publisher

Springer Science and Business Media LLC

Related search

High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients With Chronic Lymphocytic Leukemia Associated With Unfavorable Prognosis

Multidisciplinary

English

Splicing Factor Mutations Predict Poor Prognosis in Patients With De Novo Acute Myeloid Leukemia

English

Comorbidities Predict Inferior Outcomes in Chronic Lymphocytic Leukemia Treated With Ibrutinib

Cancer Research

English

The Importance of IGHV Mutational Status in Del(11q) and Del(17p) Chronic Lymphocytic Leukemia

Clinical Lymphoma, Myeloma and Leukemia

Cancer Research

English

Overview of Non-Coding Mutations in Chronic Lymphocytic Leukemia

Molecular Oncology

Cancer Research

Molecular Medicine

English

Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial

English

Prognosis and New Therapeutic Approaches in Chronic Lymphocytic Leukemia Treatment

Medicinski podmladak

English

Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib

Hematological Oncology

Cancer Research

English

Circulating VE-cadherin in Patients With Controlled Chronic Lymphocytic Leukemia

English